Matsumura Masaru, Saiura Akio, Inoue Yosuke, Ishizawa Takeaki, Mise Yoshihiro, Takahashi Yu
Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake Hospital, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
World J Surg. 2016 Apr;40(4):937-45. doi: 10.1007/s00268-015-3340-x.
The clinical course of hepatectomy in patients with preexisting bilioenteric anastomosis (BEA) is poorly understood. The aim of this study was to evaluate the potential influence of preexisting BEA on organ/space surgical site infection (SSI) after hepatectomy.
We analyzed consecutive hepatectomies performed between March 2005 and January 2015. Patients' background, operative results, and complications were compared between hepatectomies with and without preexisting BEA.
Twenty-two hepatectomies with preexisting BEA were identified among 1745 hepatectomies. The rate of organ/space SSI was much higher in hepatectomies with preexisting BEA than in those without preexisting BEA (40.9 vs. 6.4 %, P < 0.001). Multivariate analyses identified four variables as independent factors associated with organ/space SSI: liver-directed chemotherapy [odds ratio 5.06 (95 % confidence interval 2.29-10.54), P < 0.001], operative time ≥ 300 min [2.40 (1.30-4.54), P = 0.006], estimated blood loss ≥ 500 ml [2.34 (1.26-4.31), P < 0.001], and preexisting BEA [12.08 (4.54-31.32), P < 0.001]. A higher rate of organisms from intestinal flora was detected in organ/space SSI after hepatectomies with preexisting BEA (77.8 vs. 21.3 % without BEA, P = 0.002). Analysis of hepatectomies with preexisting BEA identified selection of antibiotics for prophylaxis as the sole risk factor for organ/space SSI (P = 0.049 for cefazolin versus other antibiotics targeting intestinal flora).
Preexisting BEA is an independent risk factor for the development of organ/space SSI after hepatectomy. Antibiotics targeting intestinal flora are strongly recommended for prophylaxis of infectious complications.
对于既往存在胆肠吻合术(BEA)的患者,肝切除术后的临床病程了解甚少。本研究的目的是评估既往存在的BEA对肝切除术后器官/腔隙手术部位感染(SSI)的潜在影响。
我们分析了2005年3月至2015年1月期间连续进行的肝切除术。比较了有和没有既往BEA的肝切除术患者的背景、手术结果和并发症。
在1745例肝切除术中,确定了22例既往存在BEA的肝切除术。既往存在BEA的肝切除术中器官/腔隙SSI的发生率远高于无既往BEA的肝切除术(40.9%对6.4%,P<0.001)。多因素分析确定了四个变量为与器官/腔隙SSI相关的独立因素:肝动脉化疗[比值比5.06(95%置信区间2.29-10.54),P<0.001]、手术时间≥300分钟[2.40(1.30-4.54),P=0.006]、估计失血量≥500毫升[2.34(1.26-4.31),P<0.001]以及既往存在BEA[12.08(4.54-31.32),P<0.001]。在既往存在BEA的肝切除术后器官/腔隙SSI中,检测到来自肠道菌群的微生物比例更高(77.8%对无BEA者的21.3%,P=0.002)。对既往存在BEA的肝切除术分析表明,预防性抗生素的选择是器官/腔隙SSI的唯一危险因素(头孢唑林与其他针对肠道菌群的抗生素相比,P=0.049)。
既往存在BEA是肝切除术后发生器官/腔隙SSI的独立危险因素。强烈建议使用针对肠道菌群的抗生素预防感染性并发症。